Polar Capital Holdings’s Health Catalyst HCAT Stock Holding History

Polar Capital Holdings’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-26,640	Closed	-$283K	–	310
2022 Q4	$283K	Hold	26,640	–	–	﹤0.01%	304
2022 Q3	$258K	Hold	26,640	–	–	﹤0.01%	365
2022 Q2	$386K	Buy	26,640 +11,885	+81%	+$203K	﹤0.01%	358
2022 Q1	$386K	Buy	14,755 +7,755	+111%	+$220K	﹤0.01%	390
2021 Q4	$277K	Hold	7,000	–	–	﹤0.01%	404
2021 Q3	$350K	Buy	+7,000	New	+$382K	﹤0.01%	342

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Polar Capital Holdings's HCAT Position: Q1 2023 in Review

Polar Capital Holdings sold out of Health Catalyst (HCAT) in Q1 2023, closing a stake of 26,640 shares — an estimated $283K sold.

Polar Capital Holdings first reported a position in HCAT in Q3 2021 and held it in 6 quarters. The position peaked at $386K in Q2 2022. 161 funds tracked by Wall St. Rank hold HCAT as of Q1 2023.

Polar Capital Holdings reported no remaining Health Catalyst position as of Q1 2023 after selling out during the quarter.
Polar Capital Holdings sold 26,640 Health Catalyst shares in Q1 2023, an estimated $283K.
Polar Capital Holdings first reported a position in Health Catalyst in Q3 2021 and held it in 6 quarters.
Polar Capital Holdings's Health Catalyst position peaked at $386K in Q2 2022.
161 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2023.

Based on Polar Capital Holdings's 13F filing for Q1 2023, filed 15 May 2023.